Abbonarsi

Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell–primed TH cell responses - 10/08/11

Doi : 10.1016/j.jaci.2010.12.1082 
Stefanie Gilles, PhD a, , Agnes Fekete, PhD b, , Xin Zhang a, Isabelle Beck, MS a, Cornelia Blume, PhD a, Johannes Ring, MD c, Carsten Schmidt-Weber, PhD a, Heidrun Behrendt, MD a, Philippe Schmitt-Kopplin, PhD b, d, Claudia Traidl-Hoffmann, MD a, c,
a ZAUM–Center for Allergy & Environment, Technische Universität München/Helmholtz Center, Munich, Germany 
b Department of BioGeochemistry and Analysis, Institute for Ecological Chemistry, Helmholtz Center, Munich, Germany 
c Department of Dermatology and Allergy, Technische Universität München, Munich, Germany 
d Department for Chemical-Technical Analysis Research Center Weihenstephan for Brewing and Food Quality, Technical University of Munich, Freising-Weihenstephan, Germany 

Reprint requests: Claudia Traidl-Hoffmann, MD, Department of Dermatology and Allergy, Technische Universität München, Biedersteinerstr. 29. 80802 Munich.

Abstract

Background

Water-soluble components from pollen modulate dendritic cell (DC) functions, such as IL-12 secretion and 3′-5′-cyclic adenosine monophosphate (cAMP) signaling and migration, possibly contributing to the establishment of a TH2-dominated immune response against pollen. Because these effects could not solely be attributed to the previously identified pollen-associated lipid mediators, the pollen metabolome was analyzed for candidate immunomodulatory substances.

Objective

We sought to perform an analysis of the effect of pollen-associated adenosine on DC function and TH cell differentiation.

Methods

Fractions of aqueous pollen extracts (APEs) were generated by means of ultrafiltration and were subjected simultaneously to biological tests and metabolome analysis (ultra-high-resolution mass spectrometry) and ultraperformance liquid chromatography. Effects of pollen-derived adenosine on monocyte-derived DC cAMP signaling, cytokine response, and capacity to differentiate TH cells were studied.

Results

The less than 3-kd fraction of APEs comprised thousands of substances, including adenosine in micromolar concentrations. Pollen-derived adenosine mediated A2 receptor–dependent induction of cAMP and inhibition of IL-12p70 in DCs. APEs digested with adenosine deaminase failed to mediate IL-12 inhibition. DCs of nonatopic donors exposed to APEs showed an adenosine-dependent reduced capacity to differentiate TH1 cells and an enhanced capacity to induce regulatory T cells and IL-10. DCs of atopic donors failed to induce IL-10 but instead induced IL-5 and IL-13.

Conclusion

This study identifies adenosine out of thousands of metabolites as a potent immunoregulatory substance in pollen. It acts on the level of the DC, with differential effects in atopic and nonatopic donors.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Dendritic cells, immunomodulation, adenosine, pollen, allergy

Abbreviations used : ADA, APE, cAMP, CFSE, DC, FITC, Foxp3, PE, SPE, Treg, UPLC, UPLC-PDA, UPLC–TOF-MS


Mappa


 Supported by the Faculty of Medicine of the Technische Universität München (S.G. and C.T.-H.), the Deutsche Forschungsgemeinschaft (C.T.-H.), and the Christine-Kühne-Stiftung (CK-Care).
 Disclosure of potential conflict of interest: The authors have declared they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 127 - N° 2

P. 454 - Febbraio 2011 Ritorno al numero
Articolo precedente Articolo precedente
  • Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function
  • Pia Reece, Amudhinie Thanendran, Lynn Crawford, Meri K. Tulic, Lehana Thabane, Susan L. Prescott, Roma Sehmi, Judah A. Denburg
| Articolo seguente Articolo seguente
  • Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs
  • Elad H. Kaufman, Allison D. Fryer, David B. Jacoby

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.